Healthcare provider profile · identity verified

Joseph Patrick Mcnerney, D.O.

Family Practice · CRYSTAL RIVER, FL · NPI 1801903539

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	443	135
Rosuvastatin Calcium	Rosuvastatin Calcium	401	129
Lisinopril	Lisinopril	285	82
Losartan Potassium	Losartan Potassium	249	74
Amlodipine Besylate	Amlodipine Besylate	221	66
Metoprolol Tartrate	Metoprolol Tartrate	209	61
Levothyroxine Sodium	Levothyroxine Sodium	188	55
Gabapentin	Gabapentin	187	64
Metformin Hcl	Metformin Hcl	165	51
Tamsulosin Hcl	Tamsulosin Hcl	132	50
Pantoprazole Sodium	Pantoprazole Sodium	129	51
Furosemide	Furosemide	125	39
Albuterol Sulfate Hfa	Albuterol Sulfate	124	46
Clopidogrel	Clopidogrel Bisulfate	115	32
Alprazolam	Alprazolam	113	21
Metoprolol Succinate	Metoprolol Succinate	113	40
Omeprazole	Omeprazole	111	37
Pravastatin Sodium	Pravastatin Sodium	107	27
Ozempic	Semaglutide	98	17
Glipizide	Glipizide	93	30
Meloxicam	Meloxicam	90	34
Simvastatin	Simvastatin	90	25
Trazodone Hcl	Trazodone Hcl	88	25
Allopurinol	Allopurinol	85	26
Montelukast Sodium	Montelukast Sodium	85	27
Fluticasone Propionate	Fluticasone Propionate	69	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	16
Repatha Sureclick	Evolocumab	64	12
Carvedilol	Carvedilol	63	20
Donepezil Hcl	Donepezil Hcl	63	23
Hydrochlorothiazide	Hydrochlorothiazide	63	22
Duloxetine Hcl	Duloxetine Hcl	60	14
Famotidine	Famotidine	60	17
Buspirone Hcl	Buspirone Hcl	58	15
Ezetimibe	Ezetimibe	57	20
Tramadol Hcl	Tramadol Hcl	56	20
Fluoxetine Hcl	Fluoxetine Hcl	53	17
Glimepiride	Glimepiride	53	17
Sertraline Hcl	Sertraline Hcl	53	12
Glipizide Er	Glipizide	52	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	12
Eliquis	Apixaban	49	15
Finasteride	Finasteride	48	16
Escitalopram Oxalate	Escitalopram Oxalate	47	14
Fenofibrate	Fenofibrate	46	15
Citalopram Hbr	Citalopram Hydrobromide	42	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	21
Memantine Hcl	Memantine Hcl	41	12
Alendronate Sodium	Alendronate Sodium	39	11
Spironolactone	Spironolactone	38	15
Tizanidine Hcl	Tizanidine Hcl	38	17
Atenolol	Atenolol	36	11
Farxiga	Dapagliflozin Propanediol	36	13
Potassium Chloride	Potassium Chloride	36	12
Pioglitazone Hcl	Pioglitazone Hcl	35	13
Warfarin Sodium	Warfarin Sodium	35	suppressed
Pregabalin	Pregabalin	34	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Azithromycin	Azithromycin	30	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Fluconazole	Fluconazole	26	13
Jardiance	Empagliflozin	25	11
Ondansetron Odt	Ondansetron	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Nitroglycerin	Nitroglycerin	23	12
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Prednisone	Prednisone	23	15
Buprenorphine Hcl	Buprenorphine Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	21	16
Propranolol Hcl	Propranolol Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Mupirocin	Mupirocin	20	14
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Diazepam	Diazepam	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Cilostazol	Cilostazol	17	suppressed
Cimetidine	Cimetidine	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Sulindac	Sulindac	17	suppressed
Temazepam	Temazepam	17	suppressed
Valsartan	Valsartan	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Nystatin	Nystatin	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Topiramate	Topiramate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Cozaar	Losartan Potassium	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error